Cristina Sensi

Title: Cristina Sensi: Innovator in Neurodegenerative Disease Treatment

Introduction

Cristina Sensi is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and development of chemical compounds.

Latest Patents

Cristina Sensi holds 1 patent for her work on GPR17 receptor modulators. These chemical compounds are designed to act on GPR17 receptors and are useful in the treatment or amelioration of chronic and/or acute neurodegenerative diseases. This includes conditions such as multiple sclerosis, inflammatory diseases, pathologies involving the immune system, cardiovascular diseases, and renal diseases.

Career Highlights

Throughout her career, Cristina has worked with esteemed institutions, including Università Degli Studi Di Milano and Fondazione Italiana Sclerosi Multipla—FISM Onlus. Her research has been pivotal in advancing the understanding and treatment of various neurodegenerative conditions.

Collaborations

Cristina has collaborated with notable colleagues in her field, including Maria Pia Abbracchio and Mario Alberto Battaglia. Their joint efforts have contributed to the advancement of research in neurodegenerative diseases.

Conclusion

Cristina Sensi's innovative work in developing GPR17 receptor modulators showcases her commitment to improving treatments for neurodegenerative diseases. Her contributions are invaluable to the scientific community and the patients affected by these conditions.